Invention Application
- Patent Title: BCMA-TARGETING AGENT, AND COMBINATION THERAPY WITH A GAMMA SECRETASE INHIBITOR
-
Application No.: US16608515Application Date: 2018-04-27
-
Publication No.: US20200179511A1Publication Date: 2020-06-11
- Inventor: Michael Daley , Haihui Lu
- Applicant: Michael Daley , Novartis AG
- International Application: PCT/US2018/029955 WO 20180427
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61P35/00
Abstract:
The invention provides compositions and methods for treating diseases associated with expression of BCMA. The invention also relates to a method of administering a BCMA-targeting agent which is an anti-BCMA antibody molecule or a recombinant non-antibody protein that binds to BCMA, and a gamma secretase inhibitor.
Information query
